PayPay Corporation PAYP
14.35 USD +0.17 (+1.20%)
At closeNov 13, 2026, 4:00 PM EST
14.35 0.00 0.00%
After hours · Nov 13, 4:00 PM ET
14.02 Day range 14.51
12.37 52-week range 24.56
- YTD
- -20.98%
- 1 year
- -20.98%
News
zacks.com EVTC or PAYP: Which Is the Better Value Stock Right Now? Investors interested in stocks from the Financial Transaction Services sector have probably already heard of Evertec (EVTC) and Paypay (PAYP). But which of these two companies is the best option for…
benzinga.com Cantor Fitzgerald Maintains Overweight on PayPay, Lowers Price Target to $21 Cantor Fitzgerald analyst Ramsey El-Assal maintains PayPay (NASDAQ:PAYP) with a Overweight and lowers the price target from $25 to $21.
benzinga.com Citigroup Maintains Neutral on PayPay, Lowers Price Target to $17 Citigroup analyst Bryan Keane maintains PayPay (NASDAQ:PAYP) with a Neutral and lowers the price target from $18 to $17.
benzinga.com PayPay Q2 EPS $0.16 Misses $0.19 Estimate, Sales $741.998M Beat $728.660M Estimate PayPay (NASDAQ:PAYP) reported quarterly earnings of $0.16 per share which missed the analyst consensus estimate of $0.19 by 15.79 percent. The company reported quarterly sales of $741.998 million…
benzinga.com Ladder Capital Posts Upbeat Q3 Earnings, Joins Alcoa, Hyster-Yale And Other Big Stocks Moving Higher On Friday U.S. stocks were mixed; Ladder Capital surged after beating Q3 estimates. Alcoa and other stocks also gained, led by Strata Critical Medical’s 7.5% rise.
benzinga.com Wealthfront, Orchestra Biomed, AeroVironment And Other Big Stocks Moving Higher On Thursday U.S. stocks fell, but Wealthfront surged 6.6% after beating Q2 earnings and revenue estimates; Orchestra Biomed, Clover Health and AeroVironment also rose.
benzinga.com Wolfe Research Maintains Outperform on PayPay, Raises Price Target to $21 Wolfe Research analyst Darrin Peller maintains PayPay (NASDAQ:PAYP) with a Outperform and raises the price target from $18 to $21.
benzinga.com Mizuho Maintains Outperform on PayPay, Lowers Price Target to $23 Mizuho analyst Dan Dolev maintains PayPay (NASDAQ:PAYP) with a Outperform and lowers the price target from $26 to $23.- benzinga.com Citigroup Maintains Neutral on PayPay, Lowers Price Target to $18 Citigroup analyst Bryan Keane maintains PayPay (NASDAQ:PAYP) with a Neutral and lowers the price target from $23 to $18.
- benzinga.com PayPay Q1 EPS $0.17 Beats $0.16 Estimate, Sales $688.920M Beat $668.510M Estimate PayPay (NASDAQ:PAYP) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.16 by 6.25 percent. The company reported quarterly sales of $688.920 million which…
benzinga.com This RPM International Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday Top Wall Street analysts upgraded PAYP, RPM, VRSK, AEE, and DUK stocks. See what analysts think and check out their ratings and price targets.- benzinga.com Morgan Stanley Upgrades PayPay to Overweight, Lowers Price Target to $23 Morgan Stanley analyst Mia Nagasaka upgrades PayPay (NASDAQ:PAYP) from Equal-Weight to Overweight and lowers the price target from $24 to $23.
benzinga.com DigitalOcean, Agios Pharmaceuticals, Kingsoft Cloud And Other Big Stocks Moving Higher On Tuesday US stocks were mixed, Nasdaq fell 1%. DigitalOcean shares rose after strong revenue growth and earnings guidance. Other big gainers include CRNX, MAAS, and AGIO.
benzinga.com This National Fuel Gas Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday Top Wall Street analysts changed outlook on top names. See complete list of changes at Benzinga's analyst ratings page. Considering buying NFG stock? Analysts give mixed reviews.
benzinga.com Why Oncology Institute Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket The Oncology Institute (TOI) stock rose in pre-market trading after reporting better-than-expected financial results. Other gainers include ISPC, PAYP, and EONR.